Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have earned an average recommendation of “Hold” from the twelve research firms that are currently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $26.2222.

A number of research analysts have commented on OSCR shares. Wells Fargo & Company increased their target price on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a report on Thursday, August 13th. UBS Group lifted their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. The Goldman Sachs Group reissued a “neutral” rating and set a $30.00 target price on shares of Oscar Health in a report on Tuesday, August 11th. Finally, Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th.

Oscar Health Stock Performance

Shares of OSCR stock opened at $32.53 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health has a one year low of $10.69 and a one year high of $33.55. The company’s 50-day simple moving average is $30.58 and its 200-day simple moving average is $23.27. The stock has a market capitalization of $10.04 billion, a price-to-earnings ratio of 23.24, a PEG ratio of 0.65 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.89) earnings per share. Equities analysts anticipate that Oscar Health will post 1.54 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, Director Mario Schlosser sold 31,422 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $988,221.90. Following the transaction, the director owned 449,444 shares of the company’s stock, valued at $14,135,013.80. This trade represents a 6.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 10,360 shares of Oscar Health stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $325,822.00. Following the completion of the transaction, the insider owned 248,697 shares of the company’s stock, valued at approximately $7,821,520.65. The trade was a 4.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 4,322,257 shares of company stock worth $126,818,346. 22.64% of the stock is owned by company insiders.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. GAMMA Investing LLC increased its stake in shares of Oscar Health by 32.9% during the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after acquiring an additional 357 shares during the period. Focus Partners Wealth lifted its position in Oscar Health by 1.4% in the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock worth $1,094,000 after purchasing an additional 824 shares during the period. Equitable Holdings Inc. boosted its stake in Oscar Health by 7.0% during the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after purchasing an additional 850 shares in the last quarter. IFP Advisors Inc increased its position in shares of Oscar Health by 69.5% during the 2nd quarter. IFP Advisors Inc now owns 2,139 shares of the company’s stock valued at $61,000 after purchasing an additional 877 shares during the period. Finally, Captrust Financial Advisors increased its position in shares of Oscar Health by 2.0% during the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after purchasing an additional 895 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.

Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.